CompletedNot Applicable

Kineesiotaping for Patients With LCPD

Turkey (Türkiye)30 participantsStarted 2017-09-25

Plain-language summary

Kinesiotaping is increasingly being used as a complement to musculoskeletal pain management. This study aimed to evaluate the immediate clinical efficacy of kinesiotaping on pain and pain-related symptoms of Legg-Calvé-Perthes Disease (LCPD).

Who can participate

Age range5 Years – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Having received unilateral LCPD diagnosis, * Anterior hip pain minimum three points on 10-cm Visual Analog Scale (VAS) over the previous week, * Having the following symptoms; weakness of gluteus medius muscle and patient-reported complaints on function or balance Exclusion Criteria: * Having a history of any other hip pathologies, * Having allergy to polyacrylate adhesive, * Having used analgesic medication within the previous three days.

What they're measuring

Immediate Clinical Efficacy on Activity Related Hip

Timeframe: The change between T1 (baseline) to T2 (thirty minutes later from the application)

Trial details

NCT IDNCT05840146

SponsorIstanbul University - Cerrahpasa

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-04-06

View on ClinicalTrials.gov More Legg-Calve-Perthes Disease trials